Efficacy and safety of trabectedin or dacarbazine for the treatment of patients with uterine leiomyosarcoma after prior chemotherapy: A subgroup analysis of the randomized phase 3 SAR-3007 study

Journal article

Open access

Peer reviewed

M.L. Hensley, S.R. Patel, M.V. Mehren, K. Ganjoo, R.L. Jones, A.P. Staddon, D. Rushing, M. Milhem, B.J. Monk, G. Wang, …

Gynecologic oncology, Vol.141, pp.3-3

06/01/2016

Files and links (1)

url

https://doi.org/10.1016/j.ygyno.2016.04.035View

Published (Version of record) Open

4 Record Views

Title: Efficacy and safety of trabectedin or dacarbazine for the treatment of patients with uterine leiomyosarcoma after prior chemotherapy: A subgroup analysis of the randomized phase 3 SAR-3007 study
Creators: M.L. Hensley - Memorial Sloan Kettering Cancer Center
S.R. Patel - The University of Texas MD Anderson Cancer Center
M.V. Mehren - Fox Chase Cancer Center
K. Ganjoo - Stanford Health Care
R.L. Jones - Seattle Cancer Care Alliance
A.P. Staddon - University of Pennsylvania
D. Rushing - Indiana University
M. Milhem - University of Iowa Hospitals and Clinics
B.J. Monk - Creighton University
G. Wang - Janssen
S. McCarthy - Janssen
R. Knoblauch - Janssen
T. Parekh - Janssen
R.G. Maki - Icahn School of Medicine at Mount Sinai
G.D. Demetri - Dana-Farber Cancer Institute
Publication Details: Gynecologic oncology, Vol.141, pp.3-3
Publisher: Elsevier Inc
Identifiers: 991005968797902656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article